文献速递血液透析通路

衰弱与上臂动静脉内瘘废弃风险增加相关

Frailty is associated with increased risk for upper arm arteriovenous fistula abandonment.
PubMed 文献 · J Vasc Surg · 2026-03-20

本研究回顾性分析了122例上臂自体动静脉内瘘患者,使用五因子改良衰弱指数(mFI-5)评估衰弱。结果显示,较高的衰弱评分与复合不良结局风险增加相关(OR 2.25,95%CI 1.30-4.26),主要由因未成熟而废弃内瘘的风险增加驱动(OR 3.24,95%CI 1.48-9.09)。衰弱与3个月和6个月成熟结局无关。

要点

  • 衰弱评分较高与上臂AVF废弃风险增加独立相关
  • 严重衰弱患者可能较少从AVF创建中获益
  • 衰弱与3个月和6个月成熟结局无显著关联

核心结论

  • 在新创建上臂AVF患者中,较高的衰弱与AVF废弃风险增加相关。

研究设计与样本

  • 回顾性图表审查,纳入学术三级转诊中心2年内(2022年1月至2023年12月)创建上臂AVF的患者122例,使用mFI-5评估衰弱,多变量logistic回归分析。

主要发现

  • 复合不良结局总体发生率为21%。
  • 多变量分析中,较高的衰弱与复合不良结局风险增加相关(OR 2.25;95%CI 1.30-4.26),主要由因未成熟而废弃AVF的风险增加驱动(OR 3.24;95%CI 1.48-9.09)。
  • 黑人种族与3个月内无辅助成熟失败风险增加相关(OR 2.79;95%CI 1.06-7.83)。

临床怎么用

  • 对于严重衰弱患者,应充分评估创建AVF的获益与风险,个体化选择血管通路。

局限性

  • 回顾性单中心研究,样本量有限,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The autogenous arteriovenous fistula (AVF) is the gold standard for hemodialysis access but can be limited by time to maturation. Frailty may affect AVF use in patients with end-stage renal disease. This study aims to evaluate the impact of frailty, as measured by a concise comorbidity-based tool, on AVF maturation outcomes. METHODS: A retrospective chart review of patients with upper arm AVFs created at an academic tertiary referral center over a 2-year period (January 2022-December 2023) was performed. Frailty was measured using the five-factor modified frailty index (mFI-5). A composite "poor outcome" was defined as AVF abandonment due to non-maturation, excessive (≥3 unplanned) reinterventions to achieve maturation, or mortality prior to AVF maturation. Additional outcomes included non-maturation within 3 months and non-maturation within 6 months. Multivariable logistic regression models evaluated for associations between frailty and each outcome while adjusting for preoperative characteristics. RESULTS: The cohort included 122 patients (mean age, 66 ± 12 years; 44% women; 42% Black). Of these, 50% were severely frail (mFI-5 score ≥3). Overall incidence of the composite poor outcome was 21%. Patients who experienced the composite poor outcome were more likely to have chronic obstructive pulmonary disease (35% vs 13%; P = .018), higher frailty score (3.2 ± 0.9 vs 2.4 ± 1.1; P = .001), and severe frailty (69% vs 45%; P = .047). On multivariable analyses, higher frailty was associated with increased risk for the composite poor outcome (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.30-4.26), which was driven by increased risk for AVF abandonment due to non-maturation (OR, 3.24; 95% CI, 1.48, 9.09). Frailty was not associated with 3-month and 6-month maturation outcomes (P > .05). Black race was associated with increased risk for failure of unassisted maturation within 3 months (OR, 2.79; 95% CI, 1.06-7.83). No sex differences were found in the composite poor outcome or maturation outcomes. CONCLUSIONS: Among patients with newly created upper arm AVFs, higher frailty was associated with increased risk for AVF abandonment. Patients with severe frailty may be less likely to benefit from AVF creation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Li J, Kumi M, Loh SA, et al. Frailty is associated with increased risk for upper arm arteriovenous fistula abandonment. J Vasc Surg. 2026. PMID: 41866096. doi:10.1016/j.jvs.2026.03.436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。